Advertisement
Screener

ONYX PHARMACEUTICALS INC Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31)

ONYX PHARMACEUTICALS INC Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31)

ONYX PHARMACEUTICALS INC reported Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) of $384.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-28.

Discontinued › Notes › Restructuring and Related Activities

us-gaap:RestructuringReserveSettledWithCash · last filed 2013-02-28

  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $70.00K.
  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $314.00K.
  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for the quarter ending 2011-09-30 was $1.27M.
  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for the quarter ending 2011-06-30 was -$867.60M.
  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for fiscal 2012 was $384.00K, a 88.51% decline from fiscal 2011.
  • ONYX PHARMACEUTICALS INC restructuring reserve, settled with cash (deprecated 2013-01-31) for fiscal 2011 was $3.34M.
Period endRestructuring Reserve, Settled With Cash (Deprecated 2013-01-31) 3 monthRestructuring Reserve, Settled With Cash (Deprecated 2013-01-31) 6 monthRestructuring Reserve, Settled With Cash (Deprecated 2013-01-31) 12 monthRestructuring Reserve, Settled With Cash (Deprecated 2013-01-31) 12 month as first filed
2012-12-31$384.00K
10-K · filed 2013-02-28
2012-06-30$70.00K
10-Q · filed 2012-08-06
$384.00K
derived: sum of 2 quarters · filed 2012-08-06
2012-03-31$314.00K
10-Q · filed 2012-05-04
2011-12-31$3.34M
10-K · filed 2013-02-28
$3.34K
10-K · filed 2012-02-27
2011-09-30$1.27M
10-Q · filed 2011-11-03
-$866.33M
derived: sum of 2 quarters · filed 2011-11-03
2011-06-30-$867.60M
10-Q · filed 2011-08-09